Journal profile · RESPIRATORY SYSTEM
European Clinical Respiratory Journal
ISSN 2001-8525 · Taylor & Francis Group · United Kingdom
European Clinical Respiratory Journal: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.6 (journal website); fully open access; APC about USD 2,630; median 153 days to acceptance (72 articles, last 24 months); acceptance rate 38% (journal website); 52 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
European Clinical Respiratory Journal is published by Taylor & Francis Group and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Respiratory and Cough-Related Research, together about 44.5% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
European Clinical Respiratory Journal (ECRJ) is a peer-reviewed international open access journal that publishes studies within the area of respiratory diseases. ECRJ focuses on the immunology and pathophysiology of the respiratory system, providing an understanding of disease mechanisms and how the body combats these diseases. Respiratory disease is a public health problem with several hundreds of millions currently suffering from chronic respiratory diseases, creating a large burden on both society and on the healthcare system. According to the World Health Organization (WHO), respiratory disease, including lower respiratory infections, COPD and lung cancers, accounts for 7 million deaths annually worldwide. The journal publishes under two sections, the scientific section that focuses on clinical aspects and scientific data of respiratory disease, and the educational section that focuses on papers that aim to translate the scientific data into relevant clinical recommendations. The type of work considered in each of these sections includes (but not limited to: Scientific Section Epidemiology of disease and preventive strategies Pathophysiological and immunological mechanisms of respiratory diseases Identification of potential future treatment targets and novel treatments of respiratory diseases Clinical trials including randomized, placebo controlled and observational "real life" clinical trials Clinical aspects of respiratory disease including systemic involvement and comorbidities Improved diagnostic and research methods, including imaging techniques, physiological tests, sampling techniques and biomarkers Occupational and environment related lung disease Progress in smoking intervention and cessation methods Disease and management-related issues, including self-management Updates on the status of and advances in specific disease areas, including allergy, asthma, ARDS, COPD, ILD, Cystic Fibrosis, bronchiectasis, respiratory infectious diseases, tuberculosis, lung cancer, and sleep-disordered breathing morbidity Educational Section Treatment guidelines overview Diagnostic procedures and recommendations Literature reviews and meta-analyses Case presentations and reviews of the literature Letter to the editor Expert opinions, meetings and symposium proceedings European Clinical Respiratory Journal accepts original articles, short communications and reviews. The journal operates a double-anonymized peer review policy.
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Vasiliki PanouPublisher website
Editorial board by country: none in mainland China; most named Denmark 16, Sweden 3 (19 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine20.7%
- Asthma and respiratory diseasesMedicine16.5%
- Respiratory and Cough-Related ResearchMedicine7.3%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine6%
- Respiratory Support and MechanismsMedicine5.7%
- Delphi Technique in ResearchSocial Sciences4.6%
- Lung Cancer Diagnosis and TreatmentMedicine4.5%
- Pleural and Pulmonary DiseasesMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPubMedEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.8Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher) 2025
- 2.2Publisher website ·
- SJR 2026-06
- 0.45LetPub ·
- SJR (publisher) 2025
- 0.45Publisher website ·
- SNIP 2026-06
- 0.66LetPub ·
- SNIP (publisher) 2025
- 0.66Publisher website ·
- h-index
- 32OpenAlex ·
- i10-index
- 136OpenAlex ·
- 2-year mean citedness
- 1.57OpenAlex ·
- Self-citation rate
- 6.2%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 44LetPub ·
- Downloads per year (publisher)
- 118,000Publisher website ·
- Downloads per year (publisher) 2025
- 118,000Publisher website ·
Articles by year OpenAlex count · 344 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 28 | 28 | 9 |
| 2025 | 52 | 52 | 75 |
| 2024 | 24 | 24 | 79 |
| 2023 | 26 | 26 | 160 |
| 2022 | 17 | 17 | 147 |
| 2021 | 17 | 17 | 157 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
153 daysMedian, submission to acceptance · P25–P75 109 days – 224 days
- Acceptance to online
- median 12 days (72 articles)
- Submission to online
- median 168 days
- Sample
- 72 articles with submission and acceptance dates (83 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 38%Publisher website ·
- Acceptance rate (publisher) 2025
- 38%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to first decision 2025
- 3 daysPublisher website ·
- First decision after review
- 59 daysPublisher website ·
- First decision after review 2025
- 59 daysPublisher website ·
- Acceptance to publication
- 13 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,630 / GBP 2,100 / EUR 2,520 / AUD 3,655 | Yes | CC BY, CC BY-NC | |
| OpenAlex | GBP 1,545 | — | — | |
| LetPub | GBP 1,625 / USD 2,070 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- letter to the editorLetter to the EditorLength not stated
- original articlesEuropean Clinical Respiratory Journal accepts original articles, short communications and reviews.Length not stated
- reviewReviewLength not stated
- reviewsEuropean Clinical Respiratory Journal accepts original articles, short communications and reviews.Length not stated
- short communicationShort CommunicationLength not stated
- short communicationsEuropean Clinical Respiratory Journal accepts original articles, short communications and reviews.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
European Clinical Respiratory Journal is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, …
Source ↗Publisher website ·- Peer review
Double-anonymized peer review Model summary
The journal operates a double-anonymized peer review policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor & Francis Group
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2001-8525
- Society / sponsor
- Nordic Respiratory Academy
- Latest issue on the website
- Volume 13, Issue 1 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about European Clinical Respiratory Journal
What CAS zone is European Clinical Respiratory Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Clinical Respiratory Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Clinical Respiratory Journal?
The journal's website gives an impact factor of 1.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.2, h-index 32.
How long does peer review take at European Clinical Respiratory Journal?
Based on the dates recorded on 72 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 153 days (interquartile range 109–224 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 38% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European Clinical Respiratory Journal based?
Of the 19 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Denmark (16) and Sweden (3). Counted from the institutions listed on the board page; for reference only.
Which databases index European Clinical Respiratory Journal?
According to LetPub and DOAJ records, European Clinical Respiratory Journal is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC, PubMed and Embase; that list has not been checked against each database.
Is European Clinical Respiratory Journal open access, and what is the APC?
European Clinical Respiratory Journal is a fully open-access journal. APC about USD 2,630.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .